Page last updated: 2024-08-21

quinazolines and cl 387785

quinazolines has been researched along with cl 387785 in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.09)18.2507
2000's13 (59.09)29.6817
2010's6 (27.27)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Carroll, ML; Discafani, CM; Floyd, MB; Greenberger, LM; Hollander, IJ; Husain, Z; Johnson, BD; Kitchen, D; Malo, MS; May, MK; Minnick, AA; Nilakantan, R; Shen, R; Wang, YF; Wissner, A1
Avner, ED; Frost, P; Futey, L; Sweeney, WE1
Avner, ED; Chen, Y; Frost, P; Nakanishi, K; Sweeney, WE1
Discafani, CM; Frost, P; Jackson, PE; Kinzler, KW; Montgomery, E; Nunes, M; Torrance, CJ; Vogelstein, B; Wissner, A1
Marfella-Scivittaro, C; Orellana, SA; Quiñones, A1
Avner, ED; Frost, P; Harris, PC; Qian, Q; Sweeney, WE; Torres, VE; Wang, X2
Desai, AA; Ratain, MJ1
Halmos, B; Ji, H; Kobayashi, S; Meyerson, M; Tenen, DG; Wong, KK; Yuza, Y1
Alvarez, JV; Bulmer, SE; Chen, TH; Feng, W; Frank, DA; Greulich, H; Hahn, WC; Jänne, PA; Meyerson, M; Sellers, WR; Zappaterra, M1
Erlichman, C; Goble, JM; James, CD; Lamont, JD; Mladek, AC; Rao, RD; Sarkaria, JN1
Borrás, AM; Cantley, LC; Engelman, JA; Gale, CM; Heymach, JV; Jänne, PA; Jarrell, E; Johnson, BE; Lifshits, E; Mukohara, T; Naumov, GN; Sun, J; Tracy, S; Yeap, BY; Zejnullahu, K; Zhao, X1
Golub, T; Halmos, B; Hetherington, CJ; Kobayashi, S; Lowell, AM; Meyerson, M; Monti, S; Shapiro, GI; Shimamura, T; Steidl, U; Tenen, DG1
Feng, Y; Liu, N; Lu, M; Lu, SH; Song, X; Yuan, XF1
Boggon, TJ; Dowlati, A; Halmos, B; Jin, C; Kern, JA; Kobayashi, S; Ma, PC; Tenen, DG; Yu, Z1
Ammer, H; Eisinger, DA1
Choi, YJ; Chung, JH; Kim, CH; Kim, HR; Lee, CT; Lee, JC; Lee, JS; Rho, JK; Xu, X; Yoon, HI1
Del Vecchio, S; Iommelli, F; Salvatore, M; Speranza, A; Zannetti, A1
Chang, TY; Chao, YS; Chiu, HC; Hsu, JT; Huang, CT1
Ekyalongo, RC; Fujiwara, Y; Funakoshi, Y; Imai, Y; Kataoka, Y; Kiyota, N; Minami, H; Mukohara, T; Tomioka, H1
Nakagawa, T; Yano, S1
Cai, Y; Dong, Z; Sheng, Z; Wang, J1

Other Studies

22 other study(ies) available for quinazolines and cl 387785

ArticleYear
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785).
    Biochemical pharmacology, 1999, Apr-15, Volume: 57, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Female; Mice; Mice, Nude; Models, Molecular; Neoplasm Transplantation; Neoplasms, Experimental; Phosphorylation; Quinazolines; Tumor Cells, Cultured

1999
In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor.
    Kidney international, 1999, Volume: 56, Issue:2

    Topics: Animals; Cell Division; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Enzymologic; Kidney Tubules, Collecting; Mice; Mice, Mutant Strains; Nephrons; Organ Culture Techniques; Phosphorylation; Polycystic Kidney Diseases; Protein-Tyrosine Kinases; Quinazolines

1999
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.
    Kidney international, 2000, Volume: 57, Issue:1

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mice; Mice, Inbred BALB C; Polycystic Kidney Diseases; Protein-Tyrosine Kinases; Quinazolines

2000
Combinatorial chemoprevention of intestinal neoplasia.
    Nature medicine, 2000, Volume: 6, Issue:9

    Topics: Adenomatous Polyposis Coli; Aminoquinolines; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Drug Therapy, Combination; Enzyme Inhibitors; ErbB Receptors; Mice; Mice, Mutant Strains; Organic Chemicals; Quinazolines; Sulindac

2000
cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia.
    American journal of physiology. Cell physiology, 2002, Volume: 282, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Isoquinolines; Kidney; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phenotype; Polycystic Kidney Diseases; Quinazolines; Signal Transduction; Sulfonamides

2002
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.
    Kidney international, 2003, Volume: 64, Issue:5

    Topics: Animals; Disease Models, Animal; ErbB Receptors; Gastric Lavage; Injections, Intraperitoneal; Male; Polycystic Kidney Diseases; Quinazolines; Rats; Rats, Sprague-Dawley

2003
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
    Kidney international, 2004, Volume: 66, Issue:5

    Topics: Aminoquinolines; Aniline Compounds; Animals; Cyclic AMP; Disease Models, Animal; ErbB Receptors; Female; Injections, Intraperitoneal; Intubation, Gastrointestinal; Kidney; Male; Organic Chemicals; Polycystic Kidney, Autosomal Recessive; Quinazolines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Vasopressin; Severity of Illness Index

2004
EGFR pharmacogenomics: the story continues to mutate and evolve.
    American journal of pharmacogenomics : genomics-related research in drug development and clinical practice, 2005, Volume: 5, Issue:2

    Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Pharmacogenetics; Protein-Tyrosine Kinases; Quinazolines; Randomized Controlled Trials as Topic

2005
An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.
    Cancer research, 2005, Aug-15, Volume: 65, Issue:16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Growth Processes; Cell Line, Tumor; DNA-Binding Proteins; Drug Interactions; ErbB Receptors; Gefitinib; Genes, erbB-1; Interleukin-3; Mice; Milk Proteins; Mutation; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; STAT5 Transcription Factor; Trans-Activators

2005
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
    PLoS medicine, 2005, Volume: 2, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Exons; Gefitinib; Genetic Therapy; Humans; Mice; Mice, Nude; Mutation; Neoplasms, Experimental; NIH 3T3 Cells; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; STAT3 Transcription Factor; Transfection; Tumor Stem Cell Assay

2005
Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.
    Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunoblotting; Immunoprecipitation; Models, Biological; Phosphoproteins; Phosphorylation; Protein Kinases; Quinazolines; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; Thymidine; TOR Serine-Threonine Kinases

2005
Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.
    The Journal of clinical investigation, 2006, Volume: 116, Issue:10

    Topics: Alleles; Animals; Apoptosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Gene Amplification; Humans; Lung Neoplasms; Mice; Mutation, Missense; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, ErbB-3; RNA Interference; Transfection; Xenograft Model Antitumor Assays

2006
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
    Cancer research, 2006, Dec-01, Volume: 66, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclin D; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Flavonoids; Gefitinib; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutant Proteins; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Piperidines; Quinazolines; Signal Transduction; Transcription, Genetic; Transfection

2006
[The regulation of EKI-785 to the growth of U937 cell line].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:11

    Topics: Apoptosis; Blotting, Western; Cell Proliferation; ErbB Receptors; Female; Humans; Mitogen-Activated Protein Kinase Kinases; Ovarian Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; U937 Cells

2006
Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.
    Cancer research, 2007, Nov-01, Volume: 67, Issue:21

    Topics: Cell Line, Tumor; Cyclin-Dependent Kinase 4; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship

2007
Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism.
    Molecular pharmacology, 2011, Volume: 79, Issue:2

    Topics: Blotting, Western; Cell Line; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Humans; Microfluidics; Microscopy, Confocal; Phosphorylation; Quinazolines; Receptor, IGF Type 1; Receptors, Opioid, delta; Transcriptional Activation; Tyrphostins

2011
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.
    Lung cancer (Amsterdam, Netherlands), 2011, Volume: 73, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Acinar Cell; Cell Line, Tumor; Cell Movement; Cell Shape; Deoxycytidine; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Gemcitabine; Gene Expression Profiling; Humans; Lung Neoplasms; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Quinazolines; Sequence Deletion

2011
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:3

    Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Image Processing, Computer-Assisted; Lung Neoplasms; Mice; Mice, Inbred BALB C; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Sulfonamides; Tomography, X-Ray Computed

2012
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells.
    Molecular oncology, 2012, Volume: 6, Issue:3

    Topics: Actins; Apoptosis; Blotting, Western; Cell Line; Cell Nucleus; Cell Proliferation; Cyclooxygenase 2; ErbB Receptors; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Immunoprecipitation; Molecular Motor Proteins; Myosin Heavy Chains; Myosin Type II; Protein Binding; Quinazolines; Real-Time Polymerase Chain Reaction; RNA Interference

2012
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
    International journal of oncology, 2012, Volume: 41, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Everolimus; Extracellular Signal-Regulated MAP Kinases; Fluorouracil; Gene Amplification; Humans; Paclitaxel; Quinazolines; Receptor, ErbB-2; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; Stomach Neoplasms; TOR Serine-Threonine Kinases; Trastuzumab

2012
The current state of molecularly targeted drugs targeting HGF/Met.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:1

    Topics: Acrylamides; Afatinib; Aminopyridines; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Drug Resistance, Neoplasm; Drugs, Investigational; ErbB Receptors; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Neoplasms; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Pyrrolidinones; Quinazolines; Quinolines; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor Receptor-2

2014
EGFR Inhibitor CL-387785 Suppresses the Progression of Lung Adenocarcinoma.
    Current molecular pharmacology, 2023, Volume: 16, Issue:2

    Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Quinazolines

2023